Found 513 results
As Boston's biotech sector grapples with talent migration to California, new discoveries in Alzheimer's research signal...
Replimune's new melanoma treatment gains FDA approval, while a Medicare policy change delays price negotiations for AbbV...
The NIH's proposed changes to funding eligibility may limit opportunities for international researchers on visas in the...
The recent Senate hearings on Covid-19's origins spotlight political distractions, while China's suppression of informat...
Despite high diagnosis rates, many U.S. men miss out on MRI screenings for prostate cancer, which could lead to better o...
Excluding rare disease therapies from Medicare's drug pricing pilots could significantly reduce overall savings, accordi...
A new Medicaid toolkit emphasizes stricter oversight and measurable outcomes for autism therapies, raising concerns arou...
A recent Medicare pilot proposal risks reducing savings for retail drugs. Meanwhile, merger talks between AstraZeneca an...
Ramy Farid of Schrödinger reflects on the evolving role of AI in biotech, envisioning clearer perceptions in the industr...
Moderna has launched a clinical trial for its mRNA-based Ebola vaccine, marking a significant step in combating this vir...
A child’s death in a CRISPR gene-editing trial by HuidaGene raises serious concerns about safety and regulatory oversigh...
A clinical trial indicates potential for fecal microbiome transplants to improve peanut allergy tolerance, exciting expe...
Federal health officials convene with major tech firms to discuss the future of clinical AI, aiming for safe implementat...
The FDA has approved Takeda's Orzeyful, a new orexin receptor agonist that promises to improve daytime alertness for nar...
A recent FDA panel's critical vote against a Duchenne drug highlights ongoing scrutiny of digital health practices, part...
Increased oil prices may significantly hike the cost of certain medicines, highlighting the need to reduce reliance on p...
Capricor Therapeutics faces skepticism over its Duchenne MD therapy data, while the biotech sector grapples with leaders...
In San Diego, a surge in syphilis cases highlights the challenges researchers face amid a drug shortage and complex pati...
Recent critiques of a Covid study misrepresent key findings and overlook significant challenges in assessing nonpharmace...
As advancements accelerate in rare disease therapies, LGMD patients face urgency, with time impacting their muscle funct...